We are excited to have joined the AMR Industry Alliance. The team at Disperazol has more than 40 years of experience across fundamental research and translational development of antibacterial compounds. We are pleased to be able to join our global partner organisations in the AMR Industry Alliance to co-create new ways of working that will help to overcome the scientific challenges of creating new antimicrobials and taking these to market.

…

We are proud to have been selected by CC4CARB (https://www.cc4carb-collection.org/) to support the development of our next generation compounds to reduce cyclic-di-GMP levels in Gram-negative bacteria.